Moreno-Carranza Bibiana, Bravo-Manríquez Marco, Baez Arelí, Ledesma-Colunga Maria G, Ruiz-Herrera Xarubet, Reyes-Ortega Pamela, de Los Ríos Ericka A, Macotela Yazmín, Martínez de la Escalera Gonzalo, Clapp Carmen
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Querétaro City, Querétaro, México.
Am J Physiol Regul Integr Comp Physiol. 2018 Jun 1;314(6):R902-R908. doi: 10.1152/ajpregu.00003.2018. Epub 2018 Feb 21.
The liver grows during the early postnatal period first at slower and then at faster rates than the body to achieve the adult liver-to-body weight ratio (LBW), a constant reflecting liver health. The hormone prolactin (PRL) stimulates adult liver growth and regeneration, and its levels are high in the circulation of newborn infants, but whether PRL plays a role in neonatal liver growth is unknown. Here, we show that the liver produces PRL and upregulates the PRL receptor in mice during the first 2 wk after birth, when liver growth lags behind body growth. At postnatal week 4, the production of PRL by the liver ceases coinciding with the elevation of circulating PRL and the faster liver growth that catches up with body growth. PRL receptor null mice ( Prlr-/-) show a significant decrease in the LBW at 1, 4, 6, and 10 postnatal weeks and reduced liver expression of proliferation [cyclin D1 ( Ccnd1)] and angiogenesis [platelet/endothelial cell adhesion molecule 1 ( Pecam1)] markers relative to Prlr+/+ mice. However, the LBW increases in Prlr-/- mice at postnatal week 2 concurring with the enhanced liver expression of Igf-1 and the liver upregulation and downregulation of suppressor of cytokine signaling 2 ( Socs2) and Socs3, respectively. These findings indicate that PRL acts locally and systemically to restrict and stimulate postnatal liver growth. PRL inhibits liver and body growth by attenuating growth hormone-induced Igf-1 liver expression via Socs2 and Socs3-related mechanisms.
出生后早期,肝脏生长速度先慢于身体,随后快于身体,以达到成体肝脏与体重比(LBW),该比值恒定反映肝脏健康状况。催乳素(PRL)可刺激成体肝脏生长和再生,且在新生儿循环中水平较高,但PRL是否在新生儿肝脏生长中发挥作用尚不清楚。在此,我们发现肝脏在出生后前2周会产生PRL并上调PRL受体,此时肝脏生长落后于身体生长。出生后第4周,肝脏停止产生PRL,与此同时循环中PRL升高,肝脏生长加快并赶上身体生长。与PRL受体野生型小鼠(Prlr+/+)相比,PRL受体基因敲除小鼠(Prlr-/-)在出生后1、4、6和10周时LBW显著降低,肝脏中增殖标志物[细胞周期蛋白D1(Ccnd1)]和血管生成标志物[血小板/内皮细胞黏附分子1(Pecam1)]的表达减少。然而,Prlr-/-小鼠在出生后第2周LBW增加,同时肝脏中胰岛素样生长因子1(Igf-1)表达增强,细胞因子信号转导抑制因子2(Socs2)和细胞因子信号转导抑制因子3(Socs3)在肝脏中分别上调和下调。这些发现表明,PRL在局部和全身发挥作用,限制并刺激出生后肝脏生长。PRL通过Socs2和Socs3相关机制减弱生长激素诱导的Igf-1肝脏表达,从而抑制肝脏和身体生长。